angiotensin ii has been researched along with pinocembrin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, BN; Du, GH; Gao, L; Li, L; Liu, DP; Pang, XB; Wang, L; Wang, SB | 1 |
Du, GH; Li, L; Yang, HG; Yuan, TY; Zhao, Y | 1 |
2 other study(ies) available for angiotensin ii and pinocembrin
Article | Year |
---|---|
Pinocembrin inhibits angiotensin II-induced vasoconstriction via suppression of the increase of [Ca2+]i and ERK1/2 activation through blocking AT(1)R in the rat aorta.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Blotting, Western; Calcium; Cardiac Myosins; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flavanones; In Vitro Techniques; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Myosin Light Chains; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Vasoconstriction | 2013 |
Rho kinase inhibition activity of pinocembrin in rat aortic rings contracted by angiotensin II.
Topics: Angiotensin II; Animals; Aorta; Flavanones; In Vitro Techniques; Male; Myocardial Contraction; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Signal Transduction; Vasoconstriction | 2013 |